These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28624613)

  • 1. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Nabarro LE; Lever RA; Armstrong M; Chiodini PL
    Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
    Bourque DL; Neumayr A; Libman M; Chen LH
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giardiasis: report of a case refractory to treatment.
    Iza JA; Iza SN; Olivera MJ
    Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with refractory giardiasis.
    Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
    Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
    Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Quinacrine in Nitroimidazole-resistant Giardia Duodenalis: An Old Drug for an Emerging Problem.
    Requena-Méndez A; Goñi P; Rubio E; Pou D; Fumadó V; Lóbez S; Aldasoro E; Cabezos J; Valls ME; Treviño B; Martínez Montseny AF; Clavel A; Gascon J; Muñoz J
    J Infect Dis; 2017 Mar; 215(6):946-953. PubMed ID: 28453841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis.
    Peters TE; Kreuels B; Addo MM; Tannich E; Rothe C
    Travel Med Infect Dis; 2021; 43():102090. PubMed ID: 34082086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis.
    Ydsten KA; Hellgren U; Asgeirsson H
    J Infect Dis; 2022 May; 225(10):1773-1776. PubMed ID: 34036328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giardiasis: a pharmacotherapy review.
    Escobedo AA; Cimerman S
    Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.
    Yereli K; Balcioğlu IC; Ertan P; Limoncu E; Onağ A
    Clin Microbiol Infect; 2004 Jun; 10(6):527-9. PubMed ID: 15191380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of lambliasis (literature survey)].
    Gordeeva LM
    Med Parazitol (Mosk); 1976; 45(5):593-602. PubMed ID: 799750
    [No Abstract]   [Full Text] [Related]  

  • 15. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
    Lalle M
    Infect Disord Drug Targets; 2010 Aug; 10(4):283-94. PubMed ID: 20429863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined oral and endoscopic mepacrine therapy in therapy-resistant symptomatic giardiasis].
    Rowedder A; Meier R; Wegmann W; Gyr K
    Schweiz Med Wochenschr; 1991 Sep; 121(38):1383-6. PubMed ID: 1925468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory giardiasis: a molecular appraisal from a tertiary care centre in India.
    Yadav P; Tak V; Mirdha BR; Makharia GK
    Indian J Med Microbiol; 2014; 32(4):378-82. PubMed ID: 25297020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis].
    Cacopardo B; Patamia I; Bonaccorso V; Di Paola O; Bonforte S; Brancati G
    Clin Ter; 1995 Dec; 146(12):761-7. PubMed ID: 8681495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
    Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I
    Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy in the management of giardiasis: What laboratory and clinical studies tell us, so far.
    Escobedo AA; Lalle M; Hrastnik NI; Rodríguez-Morales AJ; Castro-Sánchez E; Cimerman S; Almirall P; Jones J
    Acta Trop; 2016 Oct; 162():196-205. PubMed ID: 27349189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.